{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:08:13Z","timestamp":1788617293996,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600099"],"award-info":[{"award-number":["81600099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970121"],"award-info":[{"award-number":["81970121"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000136\uff0c82270152"],"award-info":[{"award-number":["82000136\uff0c82270152"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2021-I2M-1-073"],"award-info":[{"award-number":["2021-I2M-1-073"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2021-I2M-1-003"],"award-info":[{"award-number":["2021-I2M-1-003"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2022-I2M-2-003"],"award-info":[{"award-number":["2022-I2M-2-003"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China","award":["2019YFA0110802"],"award-info":[{"award-number":["2019YFA0110802"]}]},{"name":"Tianjin Municipal Science and Technology Commission Grant","award":["18JCQNJC11900"],"award-info":[{"award-number":["18JCQNJC11900"]}]},{"name":"the Non-profit Central Research Institute Fund of the Chinese Academy of Medical Sciences","award":["2020-PT310-011"],"award-info":[{"award-number":["2020-PT310-011"]}]},{"name":"Haihe Laboratory of Cell Ecosystem Innovation Fund","award":["HH22KYZX0022"],"award-info":[{"award-number":["HH22KYZX0022"]}]},{"name":"Clinical Research Fund of National Center for Clinical Medical Research of Hematology Diseases","award":["2023NCRCA0109"],"award-info":[{"award-number":["2023NCRCA0109"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00277-023-05317-z","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T12:31:22Z","timestamp":1687609882000},"page":"2097-2107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical features and current treatment status of essential thrombocythemia in older adults: a multicenter real-world study in China"],"prefix":"10.1007","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5442-1028","authenticated-orcid":false,"given":"Rongfeng","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1783-711X","authenticated-orcid":false,"given":"Huan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1581-0439","authenticated-orcid":false,"given":"Donglei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mankai","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3741-8518","authenticated-orcid":false,"given":"Renchi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7769-7377","authenticated-orcid":false,"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,24]]},"reference":[{"issue":"1","key":"5317_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/ajh.25303","volume":"94","author":"A Tefferi","year":"2019","unstructured":"Tefferi A, Barbui T (2019) Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. Am J Hematol 94(1):133\u2013143","journal-title":"Am J Hematol"},{"issue":"22","key":"5317_CR2","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1056\/NEJMra1406186","volume":"376","author":"JL Spivak","year":"2017","unstructured":"Spivak JL (2017) Myeloproliferative Neoplasms. N Engl J Med 376(22):2168\u20132181","journal-title":"N Engl J Med"},{"issue":"6","key":"5317_CR3","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1182\/blood-2016-10-695940","volume":"129","author":"W Vainchenker","year":"2017","unstructured":"Vainchenker W, Kralovics R (2017) Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms. Blood 129(6):667\u2013679","journal-title":"Blood"},{"issue":"22","key":"5317_CR4","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1056\/NEJMcp1816082","volume":"381","author":"A Tefferi","year":"2019","unstructured":"Tefferi A, Pardanani A (2019) Essential thrombocythemia. N Engl J Med 381(22):2135\u20132144","journal-title":"N Engl J Med"},{"issue":"4","key":"5317_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.mayocp.2018.08.022","volume":"94","author":"N Szuber","year":"2019","unstructured":"Szuber N et al (2019) 3023 Mayo clinic patients with myeloproliferative neoplasms: risk-stratified comparison of survival and outcomes data among disease Subgroups. Mayo Clin Proc 94(4):599\u2013610","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"5317_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/bjh.16380","volume":"189","author":"A Tefferi","year":"2020","unstructured":"Tefferi A et al (2020) Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera. Br J Haematol 189(2):291\u2013302","journal-title":"Br J Haematol"},{"issue":"3","key":"5317_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.6004\/jnccn.2018.7095","volume":"17","author":"NA Podoltsev","year":"2019","unstructured":"Podoltsev NA et al (2019) Impact of hydroxyurea on survival and risk of thrombosis among older patients with essential thrombocythemia. J Natl Compr Canc Netw 17(3):211\u2013219","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"5317_CR8","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/BF03324871","volume":"20","author":"ML Randi","year":"2008","unstructured":"Randi ML et al (2008) Hydroxyurea in old patients with essential thrombocythemia. Aging Clin Exp Res 20(4):376\u2013380","journal-title":"Aging Clin Exp Res"},{"issue":"5","key":"5317_CR9","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3324\/haematol.2013.101949","volume":"99","author":"P Msaouel","year":"2014","unstructured":"Msaouel P et al (2014) Abnormal platelet count is an independent predictor of mortality in the elderly and is influenced by ethnicity. Haematologica 99(5):930\u2013936","journal-title":"Haematologica"},{"key":"5317_CR10","doi-asserted-by":"crossref","unstructured":"Barbui T et al (2012) Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis). Blood 120(26):5128\u20135133. quiz 5252","DOI":"10.1182\/blood-2012-07-444067"},{"issue":"4","key":"5317_CR11","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/ajh.24293","volume":"91","author":"M Haider","year":"2016","unstructured":"Haider M et al (2016) Validation of the revised International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in 585 Mayo Clinic patients. Am J Hematol 91(4):390\u2013934","journal-title":"Am J Hematol"},{"key":"5317_CR12","doi-asserted-by":"crossref","unstructured":"Arber DA, Orazi A, Hasserjian R et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391\u20132405, 128(3):462\u2013463","DOI":"10.1182\/blood-2016-06-721662"},{"issue":"4","key":"5317_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11239-019-02029-y","volume":"49","author":"FS Seguro","year":"2020","unstructured":"Seguro FS et al (2020) Risk factors and incidence of thrombosis in a Brazilian cohort of patients with Philadelphia-negative myeloproliferative neoplasms. J Thromb Thrombolysis 49(4):667\u2013672","journal-title":"J Thromb Thrombolysis"},{"issue":"Suppl 1","key":"5317_CR14","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/S0049-3848(16)30102-5","volume":"140","author":"T Barbui","year":"2016","unstructured":"Barbui T, Falanga A (2016) Molecular biomarkers of thrombosis in myeloproliferative neoplasms. Thromb Res 140(Suppl 1):S71-75","journal-title":"Thromb Res"},{"issue":"1","key":"5317_CR15","first-page":"101","volume":"39","author":"B McMahon","year":"2013","unstructured":"McMahon B, Stein BL (2013) Thrombotic and bleeding complications in classical myeloproliferative neoplasms. Semin Thromb Hemost 39(1):101\u2013111","journal-title":"Semin Thromb Hemost"},{"issue":"23","key":"5317_CR16","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1182\/blood-2013-01-478891","volume":"121","author":"G Barosi","year":"2013","unstructured":"Barosi G et al (2013) Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project. Blood 121(23):4778\u20134781","journal-title":"Blood"},{"issue":"7571","key":"5317_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Auton A et al (2015) A global reference for human genetic variation. Nature 526(7571):68\u201374","journal-title":"Nature"},{"key":"5317_CR18","doi-asserted-by":"crossref","unstructured":"Reumers J et al (2006) SNPeffect v2.0: a new step in investigating the molecular phenotypic effects of human non-synonymous SNPs. Bioinformatics 22(17): 2183\u20132185","DOI":"10.1093\/bioinformatics\/btl348"},{"issue":"1","key":"5317_CR19","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/nar\/28.1.352","volume":"28","author":"EM Smigielski","year":"2000","unstructured":"Smigielski EM et al (2000) dbSNP: a database of single nucleotide polymorphisms. Nucleic Acids Res 28(1):352\u2013355","journal-title":"Nucleic Acids Res"},{"key":"5317_CR20","unstructured":"Forbes SA et al (2008) The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Genet. Chapter 10: p. Unit 10.11"},{"key":"5317_CR21","doi-asserted-by":"crossref","unstructured":"Mesa RA et al (2017) NCCN guidelines insights: myeloproliferative neoplasms, version 2.2018. J Natl Compr Canc Netw 15(10): 1193\u20131207","DOI":"10.6004\/jnccn.2017.0157"},{"issue":"4","key":"5317_CR22","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/1076029612453761","volume":"19","author":"T Sun","year":"2013","unstructured":"Sun T, Zhang L (2013) Thrombosis in myeloproliferative neoplasms with JAK2V617F mutation. Clin Appl Thromb Hemost 19(4):374\u2013381","journal-title":"Clin Appl Thromb Hemost"},{"issue":"6","key":"5317_CR23","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/ejh.12275","volume":"92","author":"R Fu","year":"2014","unstructured":"Fu R et al (2014) External validation and clinical evaluation of the International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in a large cohort of Chinese patients. Eur J Haematol 92(6):502\u2013509","journal-title":"Eur J Haematol"},{"issue":"5","key":"5317_CR24","first-page":"4149","volume":"15","author":"YB Nie","year":"2018","unstructured":"Nie YB et al (2018) ASXL1 mutations in Chinese patients with essential thrombocythemia. Exp Ther Med 15(5):4149\u20134156","journal-title":"Exp Ther Med"},{"issue":"6","key":"5317_CR25","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1007\/s00432-022-04067-1","volume":"149","author":"L Zhang","year":"2023","unstructured":"Zhang L et al (2023) Clinical features and next-generation sequencing landscape of essential thrombocythemia, prefibrotic primary myelofibrosis, and overt fibrotic primary myelofibrosis: a Chinese monocentric retrospective study. J Cancer Res Clin Oncol 149(6):2383\u20132392","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"5317_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/leu.2014.270","volume":"29","author":"X Cabagnols","year":"2015","unstructured":"Cabagnols X et al (2015) Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution. Leukemia 29(1):249\u2013252","journal-title":"Leukemia"},{"issue":"15","key":"5317_CR27","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood-2014-07-588426","volume":"124","author":"A Tefferi","year":"2014","unstructured":"Tefferi A et al (2014) The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants. Blood 124(15):2465\u20132466","journal-title":"Blood"},{"issue":"4","key":"5317_CR28","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3390\/cancers12040934","volume":"12","author":"A Segura-D\u00edaz","year":"2020","unstructured":"Segura-D\u00edaz A et al (2020) Thrombotic risk detection in patients with polycythemia vera: The predictive role of DNMT3A\/TET2\/ASXL1 mutations. Cancers (Basel) 12(4):934","journal-title":"Cancers (Basel)"},{"issue":"21","key":"5317_CR29","doi-asserted-by":"publisher","first-page":"4426","DOI":"10.1182\/bloodadvances.2021004668","volume":"5","author":"A Stengel","year":"2021","unstructured":"Stengel A et al (2021) Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies. Blood Adv 5(21):4426\u20134434","journal-title":"Blood Adv"},{"issue":"8","key":"5317_CR30","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.3390\/cancers12082216","volume":"12","author":"M Hautin","year":"2020","unstructured":"Hautin M et al (2020) Splicing anomalies in myeloproliferative neoplasms: paving the way for new therapeutic venues. Cancers (Basel) 12(8):2216","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5317_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1182\/bloodadvances.2016000216","volume":"1","author":"A Tefferi","year":"2016","unstructured":"Tefferi A et al (2016) Targeted deep sequencing in polycythemia vera and essential thrombocythemia. Blood Adv 1(1):21\u201330","journal-title":"Blood Adv"},{"issue":"7","key":"5317_CR32","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.18632\/aging.101500","volume":"10","author":"E Latorre","year":"2018","unstructured":"Latorre E et al (2018) Mitochondria-targeted hydrogen sulfide attenuates endothelial senescence by selective induction of splicing factors HNRNPD and SRSF2. Aging (Albany NY) 10(7):1666\u20131681","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"5317_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2141.2011.08858.x","volume":"156","author":"F Palandri","year":"2012","unstructured":"Palandri F et al (2012) Bleeding in essential thrombocythaemia: a retrospective analysis on 565 patients. Br J Haematol 156(2):281\u2013284","journal-title":"Br J Haematol"},{"issue":"4","key":"5317_CR34","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/leu.2011.258","volume":"26","author":"G Finazzi","year":"2012","unstructured":"Finazzi G et al (2012) Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria. Leukemia 26(4):716\u2013719","journal-title":"Leukemia"},{"issue":"8","key":"5317_CR35","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3324\/haematol.2016.146654","volume":"101","author":"A Alvarez-Larr\u00e1n","year":"2016","unstructured":"Alvarez-Larr\u00e1n A et al (2016) Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation. Haematologica 101(8):926\u2013931","journal-title":"Haematologica"},{"issue":"9","key":"5317_CR36","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1038\/leu.2013.163","volume":"27","author":"A Tefferi","year":"2013","unstructured":"Tefferi A et al (2013) Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study. Leukemia 27(9):1874\u20131881","journal-title":"Leukemia"},{"issue":"6","key":"5317_CR37","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1182\/blood-2012-01-403279","volume":"120","author":"F Passamonti","year":"2012","unstructured":"Passamonti F et al (2012) A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment. Blood 120(6):1197\u20131201","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05317-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05317-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05317-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T07:07:47Z","timestamp":1689232067000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05317-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,24]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["5317"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05317-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,24]]},"assertion":[{"value":"26 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the Institutional Ethics Committee of each participating center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study obtained the informed written consent of the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"The authors declare no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}